AGENUS INC Gain (Loss) on Extinguishment of Debt
AGENUS INC (AGEN) reported Gain (Loss) on Extinguishment of Debt of $6.20 million for the 12-month period ending 2021-12-31, per its 10-K filed 2024-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2024-03-14
- AGENUS INC gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $0.00.
- AGENUS INC gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $6.20M.
- AGENUS INC gain (loss) on extinguishment of debt for the quarter ending 2020-09-30 was $0.00.
- AGENUS INC gain (loss) on extinguishment of debt for the quarter ending 2020-06-30 was $0.00.
- AGENUS INC gain (loss) on extinguishment of debt for fiscal 2021 was $6.20M.
- AGENUS INC gain (loss) on extinguishment of debt for fiscal 2018 was -$10.77M.
- AGENUS INC gain (loss) on extinguishment of debt for fiscal 2015 was -$154.12K.
- AGENUS INC gain (loss) on extinguishment of debt for fiscal 2014 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 1 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 6 month as first filed | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $6.20M derived: sum of 2 quarters · filed 2024-03-14 | $6.20M 10-K · filed 2024-03-14 | ||||||
| 2021-09-30 | $6.20M 10-Q · filed 2022-11-08 | $6.20M 10-Q · filed 2022-11-08 | |||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-08-09 | -$2.72M 10-Q · filed 2020-11-09 | ||||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$2.72M 10-Q · filed 2021-08-09 | |||||||
| 2020-05-31 | $6.20M 10-Q · filed 2021-11-09 | ||||||||
| 2020-03-31 | -$2.72M 10-Q · filed 2020-05-11 | ||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | -$10.77M 10-K · filed 2021-03-16 | -$10.77M 10-K · filed 2019-03-18 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | -$10.77M 10-Q · filed 2019-11-07 | -$10.77M 10-Q · filed 2018-11-07 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$10.77M 10-Q · filed 2019-08-09 | -$10.77M 10-Q · filed 2018-08-09 | ||||||
| 2018-03-31 | -$10.77M 10-Q · filed 2019-05-10 | -$10.77M 10-Q · filed 2018-05-10 | |||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $0.00 derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | -$154.12K 10-K · filed 2018-03-16 | |||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | -$154.12K 10-Q · filed 2016-11-09 | -$154.12K derived: sum of 4 quarters · filed 2016-11-09 | |||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$154.12K 10-Q · filed 2016-08-04 | -$154.12K derived: sum of 3 quarters · filed 2016-08-04 | -$154.12K derived: sum of 4 quarters · filed 2016-08-04 | |||||
| 2015-03-31 | -$154.12K 10-Q · filed 2016-05-09 | -$154.12K derived: sum of 2 quarters · filed 2016-05-09 | -$154.12K derived: sum of 3 quarters · filed 2016-05-09 | -$154.12K derived: sum of 4 quarters · filed 2016-05-09 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | $0.00 derived: sum of 3 quarters · filed 2015-11-04 | $0.00 10-K · filed 2015-03-16 | |||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | $0.00 10-Q · filed 2015-11-04 | -$6.62M derived: sum of 4 quarters · filed 2016-03-15 | |||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $0.00 10-Q · filed 2015-08-03 | -$6.62M derived: sum of 3 quarters · filed 2016-03-15 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 | |||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-01 | -$6.62M derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | -$3.32M derived: sum of 4 quarters · filed 2016-03-15 | |||||
| 2013-12-31 | -$6.62M derived: 10-K 12 month − 10-K 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | -$3.32M derived: sum of 3 quarters · filed 2016-03-15 | -$3.32M 10-K · filed 2016-03-15 | |||||
| 2013-09-30 | $6.62M derived: 10-K 9 month − 10-Q 6 month · filed 2015-03-16 | $3.30M derived: sum of 2 quarters · filed 2015-03-16 | $3.30M 10-K · filed 2015-03-16 | $3.32M 10-Q · filed 2013-11-08 | $3.30M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-06-30 | -$3.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$3.32M 10-Q · filed 2014-08-01 | $3.32M 10-Q · filed 2013-08-09 | -$3.32M derived: sum of 3 quarters · filed 2015-03-16 | -$3.32M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | ||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | ||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 10-Q · filed 2013-11-08 | |||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | ||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-07 | $0.00 10-K · filed 2014-03-07 | ||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $0.00 10-Q · filed 2011-11-04 | |||||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-05 | ||||||||
| 2010-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.70M derived: sum of 2 quarters · filed 2013-03-18 | $2.76M 10-K · filed 2013-03-18 | ||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $1.06M 10-Q · filed 2011-11-04 | |||||||
| 2010-06-30 | $1.06M 10-Q · filed 2011-08-05 | ||||||||
| 2009-12-31 | $2.65M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |